YEAR: 2009
GAD Course 1: Burden of Illness and Challenge of Diagnosis
2009,
Standalone symposium
Looking ahead in MS: understanding and treating the whole patient
Educational financial support has been provided by Novartis
30-31 January 2009, Barcelona
GAD 1 CME Course 1: Burden of Illness and Challenge of Diagnosis
,
GAD 2 CME Course 2: Burden of Illness and Challenge of Diagnosis
,
MDD and GAD Expert Forum Meeting
Educational financial support by Eli lilly
27-28 February 2009, Rome, Italy
2nd European Brain Policy Forum
“A focus on depression and the european society”
25-26 February 2009, Brussels
Evidence Based Medicine in Schizophrenia W8
16-20 February 2009, Copenhagen
Expert Meeting
“Overcoming everyday challenges in Alzheimer’s disease”
Educational financial support has been provided by H. Lundbeck A/S
Copenhagen
13 February 2009, Copenhagen
Evidence based medicine in anxiety disorders W6
2-6 February 2009, Copenhagen
Bayer Schering Pharma International Scientific Symposium on MS
“Update course on CIS and early RRMS: MRI and MS diagnostic techniques”
28 March 2009, Istanbul
Bayer Schering Pharma International Scientific Symposium on MS
“Update course on cognition”
28 March 2009, Istanbul
10th International Psychiatry Forum Mind Matters
Educational financial support has been provided by sanofi-aventis
27-28 March 2009, Berlin
8th Narcolepsy Masterclass
“Neurobiology of sleep and its clinical implications”
Educational financial support has been provided by UCB
20-21 March 2009, Berlin
Evidence Based Medicine in Mood disorders W10
2-6 March 2009, Copenhagen
"Living with bipolar disorder: symptom control and beyond" An international meeting of minds sponsored by AstraZeneca Neuroscience
27-29 April 2009, Stockholm, Sweden
The focus on CNS disorders 2009 symposium: Advances in the management of Parkinson's disease
26 April 2009, Geneva
The focus on CNS disorders 2009 symposium: Advances in understanding and management of Alzheimer’s and Parkinson’s diseases
26 April 2009, Geneva
Focus on CNS disorders 2009 symposium: Advances in the management of Alzheimer's disease
26 April 2009, Geneva
The Lundbeck symposium Focus on CNS disorders: The patient in focus
25 April 2009, Geneva
The Lundbeck symposium Focus on CNS disorders: Sleep well, live well – a fresh look at insomnia
25 April 2009, Geneva
The Lundbeck symposium Focus on CNS disorders: Why are cognitive functioning, physical health, and early non-response important to schizophrenia patients?
25 April 2009, Geneva
Clinical Master Class 2009
22nd- 23rd April 2009, Madrid, Spain
Evidence Based Medicine in Dementia and Depression in Old Age W17
20-24 April 2009, Copenhagen
Satellite Symposium at the WPA
The potential role of novel atypical depot formulations in the treatment of schizophrenia
Educational financial support has been provided by Eli Lilly and Company
3 April, 2009 , Florence
Satellite Symposium at the WPA
The long treatment of Major depression and anxiety: are successful outcomes achievable?
Educational financial support has been provided by Eli Lilly and Company
1 April, 2009 , Florence
Satellite Symposium at the WPA
The longitudinal course of the treatment of schizophrenia
Educational financial support has been provided by Eli Lilly and Company
1 April, 2009 , Florence
International Conference in Psychiatry, Berlin 2009 (Excel)
April 2009, Berlin
International Anxiety Disorders Symposium Educational financial support has been provided by Benecke
27-28 May 2009, Amsterdam
Satellite Symposium 'Functional impairment across the lifespan' Educational financial support provided by Janssen-Cilag,
22 May 2009, Vienna
Masterclass: Parkinson’s disease and non-motor symptoms
15th and 16th May 2009, Madrid
DVD Based on the Masterclass "Parkinson's disease and non-motor symptoms"
15-16 May 2009, Madrid
Faculty Update Meeting IV - The adherence challenge : how can we overcome this major barrier to successful schizophrenia treatment?
12 May 2009 , Brussels
Faculty Update Meeting IV \ e-learning JC Academy based on FUM IV The adherence challenge : how can we overcome this major barrier to successful schizophrenia treatment?
12 May 2009 , Brussels
Evidence Based Medicine in Schizophrenia W20
11-15 May 2009, Copenhagen
Evidence Based Medicine in Mood disorders W26
22-26 June 2009, Copenhagen
ADHD - across the lifespan
19-20 June 2009, Brussels
MasterClass Excellence in Epilepsy
5th and 6th June 2009, London
Advances in science and medication for better treatment in patients with schizophrenia
5-6 June 2009, Lisbon (Portugal)
e-learning based on a Standalone Meeting "Advances in science and medication for better treatment in patients with schizophrenia"
5-6 June 2009, Lisbon
Evidence Based Medicine in Schizophrenia W35
24-28 August 2009, Copenhagen
Evidence Based Medicine in Mood Disorders Seminars W39
21-25 September 2009, Copenhagen
9th International Narcolepsy Masterclass "Remaining at the forefront of Sleep Disorders": 1st Restless Legs Syndrome Masterclass
18-19 September 2009, Istanbul
Retrospective view of the experts who attended the 22nd ECNP Congress in Istanbul
16 September 2009,
"Long-term treatment for lifelong psychiatric disorders: emerging perspectives on schizophrenia and bipolar disorder", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Schering-Plough Corporation
15 September 2009, Istanbul
"An innovative therapeutic option for depressed patients", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Servier
15 September 2009, Istanbul
"Slow wave sleep: a new player in insomnia management?", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by sanofi-aventis
14 September 2009, Istanbul
"The failure of multi-national placebo-controlled studies", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by United BioSource Corporation
14 September 2009, Istanbul
"Why do some psychiatric treatments have a broad spectrum of activity?", a Satellite symposium on the occasion of the 22nd ECNP Congress, with educational financial support provided by AstraZeneca
14 September 2009, Istanbul
"Managing life-long treatment in severe psychiatric disorders - clinical experience in the real world", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Bristol-Myers Squibb Pharmaceuticals Ltd and Otsuka Pharmaceuticals Europe Ltd
14 September 2009, Istanbul
"Cognition from the laboratory to the clinic", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
14 September 2009, Istanbul
"Relevant outcomes in dementia", Satellite symposium on the occasion of the EFNS with educational financial support provided by H. Lundbeck A/S and Merz Pharmaceuticals GmbH
14 September 2009, Florence
"Circadian basis of mood disorders" , a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Servier
13 September 2009, Istanbul
"How can we achieve early and long-term effective treatment in schizophrenia?", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Janssen Pharmaceutica NV
13 September 2009, Istanbul
"Obtaining successful outcomes in the long-term treatment of mood disorders", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Eli Lilly and Company and Boehringer Ingelheim GmbH
13 September 2009, Istanbul
"Optimizing care for patients with generalized anxiety disorder", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support profided by Pfizer Inc.
13 September 2009, Istanbul
"Bipolar disorder: the journey from diagnosis to recovery", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by AstraZeneca
13 September 2009, Istanbul
22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey
12-16 September 2009, Istanbul
e-learning based on the Satellite symposium "How can we achieve early and long-term effective treatment in schizophrenia" at the 22nd ECNP Congress, Istanbul, 13 September 2009
13 September 2009, Istanbul
"Reappraising treatment goals in the management of Parkinson's disease", Satellite symposium on the occasion of the EFNS with educational financial support provided by H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd.
13 September 2009, Florence
"Sleep well - live well - a fresh look at insomnia", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
12 September 2009, Istanbul
" Long term treatment in schizophrenia - strategies to help maximise individual patient outcome", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Eli Lilly and Company
12 September 2009, Istanbul
"Emerging focal points in depression and anxiety", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
12 September 2009, Istanbul
"New tools for bipolar disorder: acute to maintenance", a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Pfizer Inc.
12 September 2009, Istanbul
Evidence Based Medicine in Dementia and Old Age Depression W37
7-11 September 2009, Copenhagen
Sleep well - live well - a fresh look at insomnia, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
12-Sep-09, Istanbul
Long term treatment in schizophrenia - strategies to help maximise individual patient outcome, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Eli Lilly and Company
12-Sep-09, Istanbul
Emerging focal points in depression and anxiety, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
12-Sep-09, Istanbul
New tools for bipolar disorder: acute to maintenance, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Pfizer Inc.
12-Sep-09, Istanbul
Circadian basis of mood disorders , a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Servier
13-Sep-09, Istanbul
How can we achieve early and long-term effective treatment in schizophrenia?, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Janssen Pharmaceutica NV
13-Sep-09, Istanbul
Obtaining successful outcomes in the long-term treatment of mood disorders, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Eli Lilly and Company and Boehringer Ingelheim GmbH
13-Sep-09, Istanbul
Long-term treatment for lifelong psychiatric disorders: emerging perspectives on schizophrenia and bipolar disorder, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Schering-Plough Corporation
15-Sep-09, Istanbul
Slow-wave sleep: a new player in insomnia management?, a satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by sanofi-aventis
14-Sep-09, Istanbul
The failure of multi-national placebo-controlled studies, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by United BioSource Corporation
14-Sep-09, Istanbul
Optimizing care for patients with generalized anxiety disorder, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support profided by Pfizer Inc.
13-Sep-09, Istanbul
Why do some psychiatric treatments have a broad spectrum of activity?, a satellite symposium on the occasion of the 22nd ECNP congress with educational financial support provided by AstraZeneca
14-Sep-09, Istanbul
Bipolar disorder: the journey from diagnosis to recovery a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by AstraZeneca
13-Sep-09, Istanbul
Managing life-long treatment in severe psychiatric disorders - clinical experience in the real world, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Bristol-Myers Squibb Pharmaceuticals Ltd and Otsuka Pharmaceuticals Europe Ltd
14-Sep-09, Istanbul
Cognition from the laboratory to the clinic, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by H. Lundbeck A/S
14-Sep-09, Istanbul
An innovative therapeutic option for depressed patients, a Satellite symposium on the occasion of the 22nd ECNP Congress with educational financial support provided by Servier
15-Sep-09, Istanbul
22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey
12-16 September 2009, Istanbul
Masterclass "Spotlight on childhood epilepsies"
23-24 October 2009, Leuven
Evidence Based Medicine in Dementia and Old Age Depression W43
19-23 October 2009, Copenhagen
"ADHD the broad concept: from biology to social impairment"
17-18 October 2009, Berlin
Clinical Expert Forum 2009
16-17 October 2009, Rome
International Expert Meeting: "Clinical decision-making & risk/benefit evaluations in schizophrenia"
8-9 October 2009, Tallinn, Estonia
Evidence Medicine in Anxiety Disorders W 47
16-20 November 2009, Copenhagen
"The American Insomnia Survey: Methods and Results", Satellite symposium at the WASM 3rd International Congress on Sleep Medicine
10 November 2009, São Paulo